Enhancing palbociclib efficacy with low toxicity in breast cancer using polycaprolactone-based nanocarriers
Breast cancer, stands as a prevalent form of cancer that results in a significant number of fatalities annually. Palbociclib (PAL) functions by impeding the activity of CDK4 and CDK6 proteins, thereby halting the division and generation of new cells within the body. Polycaprolactone-palbociclib (PAL...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Results in Chemistry |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211715625002668 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|